Neuronetics is trading 5.18% down now at $2.65 after the Federal Reserve raised rates 25 basis points on September 16, 2026.

  • A hawkish policy outlook, firm Treasury yields, and weaker major indexes pressured rate-sensitive growth shares.
  • No clear company-specific announcement was identified; the latest notable coverage was B. Riley’s September 11 Buy initiation, not a September 16 catalyst.